chrisvoncsefalvay/vaers-outcomes huggingface dataset:
today I have low grade fever; injection site slightly swollen; minimal headache; it is achy undearneath my left armpit; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (today I have low grade fever), VACCINATION SITE SWELLING (injection site slightly swollen), HEADACHE (minimal headache) and MYALGIA (it is achy undearneath my left armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PYREXIA (today I have low grade fever), VACCINATION SITE SWELLING (injection site slightly swollen), HEADACHE (minimal headache) and MYALGIA (it is achy undearneath my left armpit). At the time of the report, PYREXIA (today I have low grade fever), VACCINATION SITE SWELLING (injection site slightly swollen), HEADACHE (minimal headache) and MYALGIA (it is achy undearneath my left armpit) outcome was unknown. Not Provided          No concomitant medications were provided. No treatment drugs were reported. Consent for follow-up by Safety - Declined   Reporter did not allow further contact
Can barely walk; Delayed reaction to my first dose; Severe vertigo; cannot drive a motor vehicle; Nausea; Pain and soreness in my right arm; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Can barely walk), VACCINATION COMPLICATION (Delayed reaction to my first dose), VERTIGO (Severe vertigo), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (cannot drive a motor vehicle) and NAUSEA (Nausea) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, the patient experienced MYALGIA (Pain and soreness in my right arm). On 19-Sep-2021, the patient experienced GAIT DISTURBANCE (Can barely walk), VACCINATION COMPLICATION (Delayed reaction to my first dose), VERTIGO (Severe vertigo), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (cannot drive a motor vehicle) and NAUSEA (Nausea). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at an unspecified dose and frequency; MECLIZINE [MECLOZINE] at an unspecified dose and frequency and DIAZEPAM (VALIUM) at an unspecified dose and frequency. On 12-Sep-2021, MYALGIA (Pain and soreness in my right arm) had resolved. At the time of the report, GAIT DISTURBANCE (Can barely walk), VACCINATION COMPLICATION (Delayed reaction to my first dose), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (cannot drive a motor vehicle) and NAUSEA (Nausea) outcome was unknown and VERTIGO (Severe vertigo) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Laboratory data included CT scan of head, MRI of head, Bloodwork, COVID test, and a neurological exam  with inconclusive results. Patient had appointment with an ENT specialist and an audiologist and had a hearing exam with inconclusive result.  No relevant concomitant medications were reported.
Patient complained not being able to raise left arm above shoulder right since 1/8/21 because of pain in shoulder. He recevied moderna dose one on 1/7, same side inj IM in deltiod. Exam: hand and arm strength equal right/left. Biceps reflex  2+ billateral. No swelling/pain on palpation of left deltiod. Over injection skin is intact. no point tenderness. No palpable Left acillary lymph nodes. MD search, no description of similar event so the pain may be temporarally after the vax, but no correlation. Disposition: Explained to patient, agreed to give him second shot on the other shoulderdeltiod. Ask him to to consult his physician re the the incidental symptoms on left shoulder.
Patient with vomiting 7 days post vaccination  no other symptoms no one else sick around patient
Soar throat, thraot constriction, difficuly (painful) swallowing; no effect on ability to breath, however.  Periodic tightness in chest; not severe.
pt woke from nap about 5PM w/t104 (o), vomiting & uncontrollable shaking; mom gave APAP beginning when got home from clinic; cont giving APAP & had not effect on fever; took pt to MD next afternoon; Blood test;  dx as DTP react;
The patient had an 8cm by 5cm area of erythema around the injection site within the last 24 hours; non tender. The patient describes slight pruritis. Benadryl to be given by the mother.
3-4 months out from the first dose and have not yet received the second dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (3-4 months out from the first dose and have not yet received the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (3-4 months out from the first dose and have not yet received the second dose). On 31-Mar-2021, PRODUCT DOSE OMISSION ISSUE (3-4 months out from the first dose and have not yet received the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.   This case was linked to MOD-2021-233418 (Patient Link).
18 YOWM PRESENTED TO PHARMACY FOR ADMINISTRATION OF 1ST DOSE OF  MODERNA COVID VACCINATION. HE MENTIONED BEING "SCARED OF NEEDLES" BUT AWKNOWLEDGED THAT HE WAS ON BOARD AND WISHED TO RECEIVE THE VACCINATION. AFTER PT WAS IN OBSERVATION  FOR HALF OF THE 15 MINUTES REQUIRED, HE STARTED LOOKING PALE AND CONFUSED. PT FAINTED, AMBULANCE WAS CALLED, PT AWOKE AFTER 5 SECONDS FROM WHEN HE FAINTED. NO SWELLING OF TONGUE, FACE OR THROAT WAS APPARENT. PT STARTED TO VOMIT. ADMINISTERED 25MG OF ORAL DIPHENDYRAMINE SYRUP. AMBULANCE ARRIVED, CHECKED VITALS WHERE ALL WITHIN NORMAL RANGE. PT WAS PICKED UP FROM FACILITY BY HIS MOTHER. CALLED PT TO CHECK ON A FEW HOURS LATER, HE STATED HE WAS DOING WELL.
Patient began exhibiting symptoms the morning of the 8th, but did not notify me until around 1230pm. He had a fever of 100.6 (oral). He said he could not move his right shoulder at all. There is a large (3 x 2 in) welt at the injection site. I made him Echinacea and Elderberry tea, and gave him both a bottle of water and a bottle of Gatorade. He refused anything to eat. We began alternating cold and warm packs on the injection site. Cold when he was hot, and hot when he was cold to try and disperse the vaccine and keep him comfortable at the same time. I gave him 500 mgs of TYLENOL and called the drs office. Drs office called back and suggested switching to ibuprofen and adding 25 mgs of BENADRYL. All Tuesday evening and so far all day today, his fever ranges between 99.8 and 101.2. The fever does break and I do not give fever reducer unless it is above 101. He is lethargic, sleepy, complains of "everything in his body hurting to include his hair". He has only had 2 bowls of chicken soup Tuesday morning. We are still actively treating similar to the flu, and as of 630pm this evening, he still has a fever of 99.9, and a headache that will not go away. If his fever is not gone tomorrow morning, I will be taking him to the local emergency room.
Stuffy nose, throat irritation, itchy eyes, high temperature, headache, drowsy
A nurse reported that the day after receiving vaccines the patient developed an injection site reaction characterized by redness, swelling and pain at the site of Acel-Imune administration. This is 1 of 3 patients from this facility who experienced this event following receipt of Acel-Imune lot 472-653.
approx 3 yrs p/ vax pt broke out w/chickenpox. pt had approx 40 lesions. rpt felt chickenpox was not related to therapy w/varicella
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Blood blister at site of vaccination.
Fever close to 103 Chills Aches  Vertigo Headache  Shortness of breath
On AM of 11SEP rapid onset of low back pain; to ER for UTI; given sulfa; muscle pain progressed up shoulders & arms; also mid back; 12SEP pain in back & shoulders inc & breathing became very labored; dx GBS;
ADMINISTERED FLU SHOT AGAIN BY MISTAKE , ALTHOUGH PATIENT HAD A FLU SHOT ON OCTOBER
Myalgia FATIGUE Narrative:  FATIGUE FOR 1 DAY. SORE ARM FOR 2 DAYS
Pt devel pruritis, urticaria, paresthesias & choking sensation approx 30min p/MMR inject recvd;
This 68-year-old gentleman was transported by ambulance to the Emergency Department where he presented with complaints of profound weakness, chills, body aches, malaise, and a 3-day history of melena.  His medical history was significant for nonalcoholic steatohepatitis with cirrhosis, gastric angiodysplasia, spontaneous bacterial peritonitis on chronic trimethoprim-sulfamethoxazole prophylaxis, Clostridioides difficile colitis, colon polyposis, type 2 diabetes with diabetic nephropathy, coronary heart disease with percutaneous coronary intervention 12 years ago requiring daily prophylactic aspirin, abdominal aortic aneurysm repair 7 years ago, pancreatic cancer, rectal carcinoid tumor, and benign prostatic hypertrophy.  On admission his hemoglobin was 6.4 g/dL with an international normalized ratio of 4.4 and a D-dimer of 2940 ng/ml. His primary diagnosis was acute on chronic blood loss anemia with recurrent upper gastrointestinal bleeding in the setting of untreated gastric angiodysplasia and coagulopathy.  He tested positive for COVID-19 infection in the setting of receipt of his fourth dose of COVID-19 vaccine 3 days previously.  Blood cultures resulted in 1 of 2 bottles positive for Klebsiella pneumoniae.  Two units of packed red blood cells were transfused, he was given IV vitamin K, and initiated on therapy with IV proton pump inhibitors, ceftriaxone, and remdesivir.  Over the course of the next two days, he improved symptomatically and was discharged to his home in medically stable condition with follow-up health care plans in place.
Pain in upper right a radiating to elbow and entire area under armpit; cold; tingling; swelling continuing down through my right hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11Feb2022 19:15 (Lot number: FJ1611) at the age of 29 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Degenerated discs" (unspecified if ongoing); "pinched nerves" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "bi-polar disorder" (unspecified if ongoing). Concomitant medication(s) included: LAMICTAL; METHADONE. Vaccination history included: Moderna (Dose Number: 2, Batch/Lot No: 033821A, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 27May2021, when the patient was 29 years old, for COVID-19 Immunization; Moderna (Dose Number: 1, Batch/Lot No: 045B21A, Location of injection: Arm Right, Vaccine Administration Time: 04:30 PM), administration date: 27Apr2021, when the patient was 28 years old, for COVID-19 Immunization. The following information was reported: AXILLARY PAIN (non-serious) with onset Feb2022, outcome "recovered" (Feb2022), described as "Pain in upper right a radiating to elbow and entire area under armpit"; NASOPHARYNGITIS (non-serious) with onset Feb2022, outcome "recovered" (Feb2022), described as "cold"; PARAESTHESIA (non-serious) with onset Feb2022, outcome "recovered" (Feb2022), described as "tingling"; PERIPHERAL SWELLING (non-serious) with onset Feb2022, outcome "not recovered", described as "swelling continuing down through my right hand". The events "pain in upper right a radiating to elbow and entire area under armpit", "cold", "tingling" and "swelling continuing down through my right hand" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of axillary pain, nasopharyngitis, paraesthesia, peripheral swelling.  Additional information: Pain in upper right a radiating to elbow and entire area under armpit with a cold tingling and swelling continuing down through her right hand. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient had no known allergies.  Follow-up attempts are completed. No further information is expected.
Tinnitus started 12/29/2020 , the day after COVID 19 vaccination and has continued after the second vaccination and is still present today
Wheezing with shortness of breath.  11/13/09 H&P received for DOS 11/11/09-11/13/09 DX: Wheezing and hypoxia.  Pt was seen at ED with wheezing and respiratory distress one day after he received H1N1 vaccine. Pt was treated with nebulizer albuterol and discharged, but readmitted again later on that same day due to worsening of wheezing. Chest examination revealed bilateral expiratory wheezing. Pt was on oxygen during the night sleep to address hypoxia and weaned to room air when asleep.  On 11/13/2009, the pt's mother took the child home against medical despite being informed about the risk of developing hypoxia while asleep if the pt is without oxygen therapy.  The hospital reported this incident to the pt's social worker as child neglect.
left shoulder pain and rash. Pain after injection on 4/20, worsened over the next few days, was seen at UC on 5/1/21 for arm pain and a D-Dimer was done and was negative no rash noted at this time.  onset of very painful rash from neck down to forearm several days after injection. Pain is described as severe, constant and sharp. Rash is classic in appearance and presentation for Shingles. Onset in close, likely causative, temporal and regional association with having received Pfizer COVID vaccine to L deltoid. For Shingles and pain, Rx valacyclovir 1g TID x7d, gabapentin 300-600mg TID PRN, oxycodone 5/325 1-2 q6 PRN, and lidoderm patches. She is overall miserable. I am asking her to f/u with me later this week.
Approx 1 wk post/vax, mother noted a red raised area, approx 20mm single. Child's scratching at area. No other sx's at this time. Instruction to mother; prevent scratching & f/u with PMD if worsening.
Allergy reaction such as runny nose sneezing - itch eyes - stuffed up nose. For a month & off & on during month also achy body.
Felt aches and fever. Mild but worsened. Fever was 101.5 degrees by 11:45 PM. Also had sore throat. Fever gone by 3/11/2010 morning, still sore throat at present (4:50Pm on 3/11). Aches almost entirely gone.
Approximately 4 after vaccine - developed scattered hives. Swelling at fingertips, toes, contact dermatitis like rash - Orapred taper, Benadryl given.
Pharyngitis after the 2nd dose; Sore throat after the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGITIS (Pharyngitis after the 2nd dose) and OROPHARYNGEAL PAIN (Sore throat after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-May-2021, the patient experienced PHARYNGITIS (Pharyngitis after the 2nd dose) and OROPHARYNGEAL PAIN (Sore throat after the 2nd dose). At the time of the report, PHARYNGITIS (Pharyngitis after the 2nd dose) and OROPHARYNGEAL PAIN (Sore throat after the 2nd dose) outcome was unknown.            Patient is wants to know, whether its safe to take antibiotic orelox for 5days No treatment and concomitant medications were provided by the reporter
Information has been received from a physician concerning a 31 year old female who 31JAN2004 was vaccinated in the deltoid with a dose of pneumococcal 23v polysaccharide vaccine. The pt was an inpatient in the hospital at that time, and was vaccinated a few hours before being discharged from the hospital. The next day, on 01FEB2004, the pt called the hospital stating that she had a lump on her arm and was diagnosed with cellulitis by her primary physician and placed on antibiotics. It was unknown why the pt was originally hospitalized. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
pt recvd vax & 3 months later pt died; @ the autopsy Hep B surface antigen was detected in the blood;
Patient was supposed to be receiving dose 1 of primary series but inadvertently got the Pfizer bivalent, which is only indicated for boosters.
The HCP administered an expired Moderna Vaccine to the patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A, 041L20A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient). On 14-Oct-2021, EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was reported that the date the vial was initially stored in the refrigerator  was Sep 8th 2021 the vial did not undergo any temperature excursions.   This case was linked to MOD-2021-366988 (Patient Link).
Fatigue, low-grade fever, nausea, rash on knees and elbows (like psoriasis), joint pains, muscle weakness progressing to inability to climb stairs or get out of bed one month later. Diagnosis: dermatomyositis. Hospitalized, received steroids, methotrexate and plaquenil, is still on medications.
REVIEWED PATIENT VACCINE CARD. IT STATED THAT SHE HAD RECEIVED 3 DOSES OF MODERNA AND HER #3 DOSE WAS ON 01.12.2022. PT WAS GIVEN MODERNA BIVALENT BOOSTER BECAUSE ACCORDING TO HER CARD SHE WAS DUE AND SHE SAID SHE HAD NEVER RECEIVED A BIVALENT BOOSTER. PT WAS MONITORED FOR 15 MINUTES AND SHE HAD NO ADVERSE REACTIONS. PT WAS A&O X 4 AND WAS DOING EXERCISES WHEN WE LEFT. PT HAD NO COMPLAINTS OR CONCERNS. UPON RETURN TO MY FACILITY I WENT TO ENTER PATIENT DOSE INTO THE IMMUNIZATION RECORD SYSTEM. HER RECORD SHOWED THAT SHE HAD ALREADY RECEIVED A BIVALENT BOOSTER IN 10.11.2022. I CALLED STAFF AT THE FACILITY, THE ADMINISTRATOR, AND I ALSO CALLED THE RESIDENTS DAUGHTER. I INFORMED BOTH OF THEM WHAT HAPPENED. I LET THEM KNOW THAT THIS IS NOT CURRENTLY AUTHORIZED BY THE CDC. I TOLD THEM SHE SHOULD BE FINE BUT TO CONTINUE TO MONITOR HER FOR ANY ADVERSE REACTIONS (ANAPHYLAXIS, SEVERE ILLNESS, ECT.) AND TO PLEASE REACH OUT TO ME IF SHE DOES EXPERIENCE ANY ADVERSE REACTIONS. I INFORMED THEM THAT I WOULD FILE A VAERS REPORT AND MY CONTACT INFORMATION WAS GIVEN. THEY HAD NO QUESTIONS OR CONCERNS AT THIS TIME. STAFF WAS INFORMED @ 1245 AND DAUGHTER @ 1250. AT 1245 STAFF STATED THAT PATIENT WAS NOT EXPERIENCING ANY ADVERSE REACTIONS.
Information has been received regarding a case in litigation from a lawyer, an elderly female patient of unknown age, and her spouse. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 24-SEP-2014, at age 69, the patient was administered the ZOSTAVAX vaccine by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician for the following injury resulting from her ZOSTAVAX use: Herpes zoster. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the herpes zoster is unknown. Additional information has been requested.
A had a little soreness at the injection site. I began to feel symptoms on 12/18/2022 I felt like I was getting a bad cold. I tested positive for COVID-19 on 12/19/2022.  I contacted my local hospital to discuss my symptoms and was advised to rest and drink fluids but if I got worse to come in. I took Coricidin for my symptoms. By day nine, I tested negative for COVID-19.
Myalgia, Fever, red area on arm at injection site Narrative: went to PCP and was tested negative for covid. Missed work due to vaccine reaction
pain in the arm; This is a spontaneous report from a contactable consumer. This (Age: 71; Unit: Unknown) male consumer (Patient) reported that: Who received (BNT162B2) Pfizer-Biontech Covid-19 Vaccine solution for injection, dose 1 (Lot number and expiry date was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reporter received the first shot of the Pfizer covid vaccine (where he experienced only some pain in the arm), and his second dose was scheduled on 05Mar. He was scheduled to travel the next day and wants to know if it is okay to proceed with that. Outcome of the events was unknown   Follow-up attempts are completed. No further information is expected.
Patient had Shortness of breath about 15 min -20 minutes after  getting moderna vaccination. Measured the blood pressure which was about 200/100. Pt refused to call 911. Provided patient diphendyramine 20ml  12.5mg/5ml orally route. Patient refused to go ER/ Epi-pen. Patient felt better after resting for 30 mins.
patient received full 0.5ml dose as booster dose; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (patient received full 0.5ml dose as booster dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On an unknown date, the patient experienced OVERDOSE (patient received full 0.5ml dose as booster dose). At the time of the report, OVERDOSE (patient received full 0.5ml dose as booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter.